(Q47745303)

5 February 2018

title

The antidepressant-like action of mGlu5 receptor antagonist, MTEP, in the tail suspension test in mice is serotonin dependent. (English)

1 reference

5 February 2018

Agnieszka Pałucha-Poniewiera

0 references

Katarzyna Stachowicz

4

0 references

Piotr Brański

object named as

Piotr Brański

series ordinal

2

0 references

object named as

Agnieszka Pałucha-Poniewiera

series ordinal

1

0 references

Andrzej Pilc

series ordinal

6

object named as

Andrzej Pilc

1 reference

5 February 2018

3

Joanna M Wierońska

1 reference

5 February 2018

5

Anna Sławińska

1 reference

5 February 2018

publication date

1 January 2014

1 reference

5 February 2018

published in

Psychopharmacology

1 reference

5 February 2018

volume

231

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

page(s)

97-107

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-013-3206-6

exact match

0 references

cites work

Ketamine for depression: where do we go from here?

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

A review of central 5-HT receptors and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Antidepressant-like effects of mGluR1 and mGluR5 antagonists in the rat forced swim and the mouse tail suspension tests.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Antidepressant effects of ketamine in depressed patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Metabotropic glutamate receptor 5 antagonist-induced stimulation of hypothalamic-pituitary-adrenal axis activity: interaction with serotonergic systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

The behavioral profile of the potent and selective mGlu5 receptor antagonist 3-[(2-methyl-1,3-thiazol-4-yl)ethynyl]pyridine (MTEP) in rodent models of anxiety

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

MGS0039: a potent and selective group II metabotropic glutamate receptor antagonist with antidepressant-like activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Pharmacology and functions of metabotropic glutamate receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

3-[(2-Methyl-1,3-thiazol-4-yl)ethynyl]-pyridine: a potent and highly selective metabotropic glutamate subtype 5 receptor antagonist with anxiolytic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

The tail suspension test as a model for assessing antidepressant activity: review of pharmacological and genetic studies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Reduced metabotropic glutamate receptor 5 density in major depression determined by [(11)C]ABP688 PET and postmortem study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

A randomized add-on trial of an N-methyl-D-aspartate antagonist in treatment-resistant bipolar depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Identification of a serotonin/glutamate receptor complex implicated in psychosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Interactive effects of mGlu5 and 5-HT2A receptors on locomotor activity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Serotonergic modulation of the limbic system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Rapid decrease in depressive symptoms with an N-methyl-d-aspartate antagonist in ECT-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Simultaneous alterations of brain and plasma serotonin concentrations and liver cytochrome P450 in rats fed on a tryptophan-free diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Metabotropic glutamate 5 receptor antagonism is associated with antidepressant-like effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Selective serotonin reuptake inhibitors potentiate the rapid antidepressant-like effects of serotonin4 receptor agonists in the rat

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

5-Hydroxytryptamine2A (5-HT2A) receptor regulation in rat prefrontal cortex: interaction of a phenethylamine hallucinogen and the metabotropic glutamate2/3 receptor agonist LY354740.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Serotonergic targets in depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Diabetes attenuates the antidepressant-like effect mediated by the activation of 5-HT1A receptor in the mouse tail suspension test

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Activation of mGlu2/3 metabotropic glutamate receptors negatively regulates the stimulation of inositol phospholipid hydrolysis mediated by 5-hydroxytryptamine2A serotonin receptors in the frontal cortex of living mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Depletion of serotonin and catecholamines block the acute behavioral response to different classes of antidepressant drugs in the mouse tail suspension test.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Modulation of the neuronal dopamine transporter activity by the metabotropic glutamate receptor mGluR5 in rat striatal synaptosomes through phosphorylation mediated processes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Potential antidepressant-like effect of MTEP, a potent and highly selective mGluR5 antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Activation of the mGlu7 receptor elicits antidepressant-like effects in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Metabotropic glutamate receptor ligands as possible anxiolytic and antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

The antidepressant-like action of metabotropic glutamate 7 receptor agonist N,N'-bis(diphenylmethyl)-1,2-ethanediamine (AMN082) is serotonin-dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

On the mechanism of the antidepressant-like action of group II mGlu receptor antagonist, MGS0039.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Immunohistochemical localization of a metabotropic glutamate receptor, mGluR5, in the rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Anxiolytic-like action of MTEP expressed in the conflict drinking Vogel test in rats is serotonin dependent.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Investigational NMDA receptor modulators for depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Potential anxiolytic- and antidepressant-like effects of MPEP, a potent, selective and systemically active mGlu5 receptor antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Acute tryptophan depletion in C57BL/6 mice does not induce central serotonin reduction or affective behavioural changes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Serotonergic/glutamatergic interactions: the effects of mGlu 2/3 receptor ligands in rats trained with LSD and PCP as discriminative stimuli

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Group II metabotropic glutamate receptor modulation of DOI-induced c-fos mRNA and excitatory responses in the cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-013-3206-6

Physiological antagonism between 5-hydroxytryptamine(2A) and group II metabotropic glutamate receptors in prefrontal cortex

21 January 2018

1 reference

12 December 2020

Negative allosteric modulation of metabotropic glutamate receptor 5 results in broad spectrum activity relevant to treatment resistant depression.

1 reference

12 December 2020

GR 127935 blocks the locomotor and antidepressant-like effects of RU 24969 and the action of antidepressants in the mouse tail suspension test

1 reference

12 December 2020

mGlu2/3 and mGlu5 receptors: potential targets for novel antidepressants

1 reference

12 December 2020

The tail suspension test: a new method for screening antidepressants in mice

1 reference

12 December 2020

Distribution of metabotropic glutamate receptor mGluR5 immunoreactivity in rat brain

1 reference

12 December 2020

Sub-chronic dietary tryptophan depletion – An animal model of depression with improved face and good construct validity

1 reference

12 December 2020

10.1007/S00213-013-3206-6

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

23958941

1 reference

5 February 2018